Tigecycline is a topic covered in the Johns Hopkins Antibiotic (ABX) Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Complicated skin and skin structure infections (including those caused by MRSA and vancomycin-susceptible E. faecalis).
    • Author’s comment: avoid in severe infections +/- bacteremia.
  • Complicated intra-abdominal infections (as a single agent).
    • Author’s comment: avoid in severe infections +/- bacteremia.
  • Community-acquired bacterial pneumonia caused by S. pneumoniae (PCN-susceptible isolates), H. influenzae (beta-lactamase negative isolates), and Legionella pneumophila.
    • Author’s comment: not a first-line agent and generally not used for CAP.

NON-FDA APPROVED USES

  • HAP/VAP due to MDR GNR, but high rates of clinical failure reported [2].
    • In critically ill patients, consider using tigecycline in combination with carbapenem or colistin.

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: December 14, 2015